(MedPage Today) — In patients with type 2 diabetes, GLP-1 receptor agonists were associated with a higher risk for gastroesophageal reflux disease (GERD) compared with SGLT-2 inhibitors. (Annals of Internal Medicine)
A similar study in Gastro…
Source link : https://www.medpagetoday.com/gastroenterology/gerd/116546
Author :
Publish date : 2025-07-17 16:41:00
Copyright for syndicated content belongs to the linked Source.
